Voyager Therapeutics (VYGR) Net Margin Growth (5y) (2020 - 2026)
Voyager Therapeutics (VYGR) Net Margin Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Voyager Therapeutics | 184.74 Mn | 43.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26,641.00 |
| Dec 31, 2025 | 6,524.00 |
| Sep 30, 2025 | -28,134.00 |
| Jun 30, 2025 | -57,396.00 |
| Mar 31, 2025 | -30,978.00 |
| Dec 31, 2024 | -50,884.00 |
| Sep 30, 2024 | 3,672.00 |
| Jun 30, 2024 | -5,849.00 |
| Mar 31, 2024 | 46,470.00 |
| Dec 31, 2023 | 118,465.00 |
| Sep 30, 2023 | 40,755.00 |
| Jun 30, 2023 | 53,866.00 |
| Mar 31, 2023 | 219,772.00 |
| Dec 31, 2022 | 171,017.00 |
| Sep 30, 2022 | 207,652.00 |
| Jun 30, 2022 | -107,702.00 |
| Mar 31, 2022 | -210,281.00 |
| Dec 31, 2021 | 64,159.00 |
| Sep 30, 2021 | -142,421.00 |
| Jun 30, 2021 | -289,674.00 |